Citrate in the diagnosis of prostate cancer

Prostate

Volumn 38, Issue 3, 1999, Pages 237-245

  Costello, L C ^a,c   Franklin, R B ^a   Narayan, P ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

Benign prostatic hyperplasia; Citrate metabolism; Magnetic resonance spectroscopy; Prostate cancer; Zinc

Indexed keywords

CHOLINE; CITRIC ACID; LACTIC ACID; ZINC;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL TRIAL; EARLY DIAGNOSIS; HUMAN; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR VOLUME;

CITRIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; PROTONS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033557163     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990215)38:3<237::AID-PROS8>3.0.CO;2-O     Document Type: Article

References (34)

1. Cooper JE, Farid I. The role of citric acid in the physiology of the prostate. A chromatographic study of citric acid cycle intermediates in benign and malignant prostatic tissue. J Surg Res 1963; 3:112-121.
2. Cooper JE, Farid I. The role of citric acid in the physiology of the prostate. Lactic/citrate ratios in benign and malignant prostatic homogenates as an index of prostatic malignancy. J Urol 1964; 92:533-536.
3. Costello LC, Littleton G, Franklin RB. Regulation of citrate related metabolism in normal and neoplastic prostate. In: Sharma RK, Criss WE, editors. Endocrine control in neoplasia. New York: Raven Press; 1978. p 303-313.
4. Costello LC, Franklin RB. Concepts of citrate production and secretion by prostate: 1. Metabolic relationships. Prostate 1991; 18:25-46.
5. Costello LC, Franklin RB. Concepts of citrate production and secretion by prostate: 2. Hormonal relationships in normal and neoplastic prostate. Prostate 1991;19:181-205.
6. Costello LC, Franklin RB. Citrate metabolism of normal and malignant prostate epithelial cells. Urology 1997;50:3-12.
7. Franklin RB, Costello LC. Intermediary energy metabolism of normal and malignant prostate epithelial cells. In: Naz RK, editor. Prostate: basic and clinical aspects. New York: CRC Press; 1997. p 115-150.
8. Costello LC, Franklin RB. The novel role of zinc in the intermediary metabolism of prostate epithelial cells and its implications in prostate malignancy. Prostate 1998;35:285-296.
9. Cooper JF, Imfeld H. The role of citric acid in the physiology of the prostate: a preliminary report. J Urol 1959;81:157-163.
10. Marberger H, Marberger E, Mann T, Lutwak-Mann C. Citric acid in human prostatic secretion and metastasizing cancer of prostate gland. Br Med J 1962;1:835-836.
11. Sillerud LO, Halliday KR, Griffey RH, Fenoglia-Preiser C, Sheppard S. In vitro 13C NMR spectroscopy of the human prostate. Magn Reson Med 1988;8:224-230.
12. Halliday KR, Fenoglio-Preiser C, Sillerud LO. Differentiation of human tumors from non-malignant tissue by natural abundance 13C NMR spectroscopy. Magn Reson Med 1988;7:384-411.
13. Schiebler ML, Schnall MD, Pollack HM, Lenkinski RE, Toamszewski JE, Wein AJ, Whittington R, Rauschning W, Kressel HY. Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 1993;189:339-352.
14. Narayan D, Vigneron DB, Jajodia CM, Anderson CM, Hedgcock MW, Tanagho EA, James TL. Transrectal probe for 1H MRI and 31P MR spectroscopy of the prostate gland. J Magn Reson 1989; 11:209-220.
15. Thomas MA, Narayan P, Kurhanewicz J, Jojadia P, Weiner MW. 1H MR spectroscopy of normal and malignant human prostate in vivo. J Magn Reson 1990;87:610-619.
16. Kurhanewicz J, Thomas A, Jajodia P, Weiner M, James TL, Vigneron D, Narayan P. 31P spectroscopy of the human prostate gland in vivo using a transrectal probe. Magn Reson Med 1991; 22:404-413.
17. Narayan P, Kurhanewicz J. Magnetic resonance spectroscopy in prostate disease: diagnostic possibilities and future developments. Prostate 1992;4:43-50.
18. Kurhanewicz J, Dahiya R, MacDonald JM, Chang LH, James TL, Narayan P. Citrate alterations in primary and metastatic human prostate adenocarcinomas. 1H magnetic resonance spectroscopy and biochemical study. Magn Reson Med 1993;29:149-157.
19. Schnall MD, Lekinski RL, Pollack HM, Imai Y, Kressel HY. Prostate MR imaging with an endorectal surface coil. Radiology 1989;172:570-574.
20. Fowler AH, Pappas AA, Holder JC, Finkbeiner AE, Dalrymple GV, Mullins MS, Sprigg JR, Komoroski RA. Differentiation of human prostate cancer from benign hypertrophy by in vitro 1H NMR. Magn Reson Med 1992;25:140-147.
21. Cornel EB, Smits GAHJ, Oosterhof GON, Karthaus HFM, Debruyne FMJ, Schalken JA, Heerschap A. Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by 1H and 31P magnetic resonance spectroscopy. J Urol 1993;150:2019-2014.
22. Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak HJ, MacDonald JM, Konety B, Narayan P. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 1995;45:459-467.
23. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carrol P, Nelson SJ. Three dimensional hydrogen-1 MR spectroscopic imaging of the in situ human prostate with high spatial resolution. Radiology 1996;198:795-805.
24. Heerschap A, Jager GJ, Van Der Graff M, Barentsz JO, De La Rosette JJMCH, Oosterhof GON, Ruijter ETG, Ruijs SHJ. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. Anticancer Res 1997;17:1455-1460.
25. Kaji Y, Kurhanewicz J, Hricak H, Sokolov DL, Huang LR, Nelson SJ, Vigneron DB. Localizing prostate cancer in the presence of postbiopsy changes in MR images: role of proton MR spectroscopic imaging. Radiology 1998;296:785-790.
26. Liney GP, Turnbull LW, Lowry M, Turnbull LS, Knowles AJ, Horsman A. In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. Magn Reson Imaging 1997;15:1177-1186.
27. Costello LC, Franklin RB. Bioenergetic theory of prostate malignancy. Prostate 1994;25:162-166.
28. Schiebler ML, Miyamoto KK, White M, Maygarden SJ, Mohler JL. In vitro high resolution 1H-spectroscopy of the human prostate: benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma. Magn Reson Med 1993;29:285-291.
29. Lowry M, Liney GP, Turnbull LW, Manton DJ, Blackband SJ, Horsman A. Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: zonal and agerelated differences. Magn Reson Med 1996;36:352-358.
30. Price D. Comparative aspects of development and structure in the prostate. NCI Monogr 1963;12:1-27.
31. McNeal JE. Anatomy of the prostate. Prostate 1980;1:3-13.
32. Parivar F, Hricak H, Shinhara K, Kurhanewicz J, Vigneron DB, Nelson SJ, Carroll PR. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Adult Urol 1996,48:594-599.
33. Gonic P, Oberleas D, Knechtges T, Prasad AS. Atomic absorption determination of zinc in the prostate. Invest Urol 1969;6: 345-347.
34. Habib FK, Mason MK, Smith PH, Stitch SR. Cancer of the prostate: early diagnosis by zinc and hormone analysis. Br J Cancer 1979;39:700-704.